CRISPR

CRISPR1-zng1a

ID
ZDB-CRISPR-230119-6
Name
CRISPR1-zng1a
Previous Names
  • CRISPR1-cbwd
Target
Sequence
5' - GACCCACAGCTCAGATCC - 3'
ZFIN BLAST NCBI BLAST Ensembl
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
vu1 zng1a
vu2 zng1a
Expression
Gene expression in Wild Types + CRISPR1-zng1a
No data available
Phenotype
Phenotype resulting from CRISPR1-zng1a
No data available
Phenotype of all Fish created by or utilizing CRISPR1-zng1a
Phenotype Fish Conditions Figures
whole organism semi-viable, abnormal zng1avu1/vu1 chemical treatment by environment: N-acyl-amino acid, chemical treatment by environment: N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine Fig. 5,  Fig. S5 from Weiss et al., 2022
whole organism dead, abnormal zng1avu1/vu1 chemical treatment by environment: N-acyl-amino acid Fig. 5,  Fig. S5 from Weiss et al., 2022
pericardium edematous, abnormal zng1avu1/vu1 chemical treatment by environment: N-acyl-amino acid Fig. 5 from Weiss et al., 2022
whole organism semi-viable, abnormal zng1avu1/vu1 chemical treatment by environment: O-(chloroacetylcarbamoyl)fumagillol, chemical treatment by environment: N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine Fig. 5 from Weiss et al., 2022
ball edematous, abnormal zng1avu1/vu1 chemical treatment by environment: N-acyl-amino acid Fig. 5 from Weiss et al., 2022
whole organism dead, abnormal zng1avu1/vu1 chemical treatment by environment: O-(chloroacetylcarbamoyl)fumagillol Fig. 5 from Weiss et al., 2022
swim bladder uninflated, abnormal zng1avu1/vu1 chemical treatment by environment: N-acyl-amino acid Fig. 5 from Weiss et al., 2022
whole organism decreased length, abnormal zng1avu1/vu1 standard conditions Fig. 5 from Weiss et al., 2022
whole organism viability, exacerbated zng1avu1/vu1 chemical treatment by environment: O-(chloroacetylcarbamoyl)fumagillol, chemical treatment by environment: N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine Fig. 5 from Weiss et al., 2022
whole organism zng1a expression decreased amount, abnormal zng1avu1/vu1 control Fig. 5 from Weiss et al., 2022
anal fin anterior side decreased height, abnormal zng1avu1/vu1 standard conditions Fig. 5 from Weiss et al., 2022
whole organism viability, exacerbated zng1avu1/vu1 chemical treatment by environment: N-acyl-amino acid, chemical treatment by environment: N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine Fig. 5,  Fig. S5 from Weiss et al., 2022
cranium morphology, abnormal zng1avu1/vu1 chemical treatment by environment: N-acyl-amino acid Fig. 5 from Weiss et al., 2022
whole organism zng1a expression decreased amount, abnormal zng1avu1/vu1 chemical treatment by environment: N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine Fig. 5 from Weiss et al., 2022
whole organism semi-viable, abnormal zng1avu2/vu2 chemical treatment by environment: N-acyl-amino acid, chemical treatment by environment: N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine Fig. 5,  Fig. S5 from Weiss et al., 2022
pericardium edematous, abnormal zng1avu2/vu2 chemical treatment by environment: N-acyl-amino acid Fig. 5 from Weiss et al., 2022
whole organism dead, abnormal zng1avu2/vu2 chemical treatment by environment: N-acyl-amino acid Fig. 5,  Fig. S5 from Weiss et al., 2022
whole organism semi-viable, abnormal zng1avu2/vu2 chemical treatment by environment: O-(chloroacetylcarbamoyl)fumagillol, chemical treatment by environment: N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine Fig. 5 from Weiss et al., 2022
ball edematous, abnormal zng1avu2/vu2 chemical treatment by environment: N-acyl-amino acid Fig. 5 from Weiss et al., 2022
swim bladder uninflated, abnormal zng1avu2/vu2 chemical treatment by environment: N-acyl-amino acid Fig. 5 from Weiss et al., 2022
whole organism dead, abnormal zng1avu2/vu2 chemical treatment by environment: O-(chloroacetylcarbamoyl)fumagillol Fig. 5 from Weiss et al., 2022
whole organism decreased length, abnormal zng1avu2/vu2 standard conditions Fig. 5 from Weiss et al., 2022
whole organism viability, exacerbated zng1avu2/vu2 chemical treatment by environment: O-(chloroacetylcarbamoyl)fumagillol, chemical treatment by environment: N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine Fig. 5 from Weiss et al., 2022
whole organism zng1a expression decreased amount, abnormal zng1avu2/vu2 control Fig. 5 from Weiss et al., 2022
anal fin anterior side decreased height, abnormal zng1avu2/vu2 standard conditions Fig. 5 from Weiss et al., 2022
whole organism viability, exacerbated zng1avu2/vu2 chemical treatment by environment: N-acyl-amino acid, chemical treatment by environment: N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine Fig. 5,  Fig. S5 from Weiss et al., 2022
whole organism zng1a expression decreased amount, abnormal zng1avu2/vu2 chemical treatment by environment: N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine Fig. 5 from Weiss et al., 2022
cranium morphology, abnormal zng1avu2/vu2 chemical treatment by environment: N-acyl-amino acid Fig. 5 from Weiss et al., 2022
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to report issues or recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.